Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Filings indexed 2,730 across all filing types
Latest filing 2025-03-07 Director's Dealing
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
114年02月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, general managers, deputy general managers, and major shareholders. It provides data on stock types, holdings at appointment, changes in holdings during the month, and current holdings. The content is focused on insider share transactions and holdings disclosures. There is no indication of financial statements, earnings data, management discussion, or other report types. The document is not a report itself but a regulatory disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is substantial and contains actual data, not just an announcement or certification. Therefore, the appropriate classification is DIRS with high confidence.
2025-03-07 Chinese
114年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current and pledged shares. It lists individual names, titles, and share counts, focusing on insider shareholdings and related disclosures. There is no indication of financial statements, earnings data, or report publication announcements. The content aligns with reporting of insider share transactions or holdings by company directors and executives. Therefore, the document fits the category of Director's Dealing (DIRS). The document length is 3736 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report.
2025-03-07 Chinese
113年度應收帳款周轉率
Fund Information / Factsheet Classification · 85% confidence The document is very short (283 characters) and contains financial ratio data (accounts receivable turnover and average collection days) for two fiscal years (112 and 113). It includes a note about explaining significant changes in accounts receivable turnover. There is no indication of a full financial report, management discussion, or regulatory filing. The content resembles a brief financial fact summary or a snippet of financial metrics rather than a full report or announcement. Given the brevity and nature of the data, it best fits the category of Fund Information / Factsheet (FS), which is for brief summaries of key company financials and facts.
2025-03-06 Chinese
113年度存貨週轉率
Regulatory Filings Classification · 95% confidence The document is very short (279 characters) and contains a brief table with inventory turnover rates and average sales days for two fiscal years (112年度 and 113年度). There is a note about explaining significant changes in inventory turnover rates. The content is a simple data disclosure without detailed financial statements, management discussion, or comprehensive reporting. It does not present a full report, nor does it announce a report publication. It appears to be a regulatory disclosure of specific financial metrics, likely a regulatory filing or compliance disclosure. Given the brevity and nature, it fits best under Regulatory Filings (RNS) as a miscellaneous financial data disclosure that does not fit other categories.
2025-03-06 Chinese
113年度毛利率
Fund Information / Factsheet Classification · 90% confidence The document is very short (393 characters) and contains a brief financial summary table with annual revenue, cost, gross profit, and gross margin percentages for two years. It lacks detailed financial statements, management discussion, or comprehensive analysis. There is no indication that this is a full annual or interim report, nor is it an announcement of a meeting or voting results. Given the brevity and nature of the data, it appears to be a brief financial summary or factsheet rather than a full report. Therefore, the best fitting category is Fund Information / Factsheet (FS).
2025-03-06 Chinese
113年度營益分析
Interim / Quarterly Report Classification · 95% confidence The document contains detailed quarterly and annual financial data including revenue, gross margin, operating profit margin, pre-tax profit margin, and after-tax profit margin for multiple fiscal years. The data is structured by fiscal periods such as first quarter, half-year, third quarter, and full year. This indicates a comprehensive financial report for periods shorter than a full fiscal year, consistent with an Interim / Quarterly Report. The document length is short (1068 characters), but it contains substantive financial data rather than just an announcement or certification. Therefore, it is classified as an Interim / Quarterly Report (IR). FY 2024
2025-03-06 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.